- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
CTC Alternative Strategies Ltd. Boosts Johnson & Johnson Stake
Investment firm increases holding in pharmaceutical giant by over 3,100%
Mar. 20, 2026 at 8:03am
Got story updates? Submit your updates here. ›
CTC Alternative Strategies Ltd. significantly increased its stake in Johnson & Johnson (NYSE:JNJ) during the third quarter, according to a recent SEC filing. The investment firm now owns 121,150 shares of the company's stock, worth approximately $22.46 million, after acquiring an additional 117,410 shares during the period.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. The significant increase in CTC Alternative Strategies' position in the company suggests the firm sees long-term value and growth potential in the stock.
The details
According to the SEC filing, CTC Alternative Strategies Ltd. raised its holdings in Johnson & Johnson by 3,139.3% during the third quarter. The firm now owns 121,150 shares of the company's stock, making it one of the company's largest institutional investors. Johnson & Johnson comprises approximately 27.2% of CTC Alternative Strategies' portfolio, making it the firm's biggest holding.
- CTC Alternative Strategies Ltd. increased its position in Johnson & Johnson during the third quarter of 2026.
The players
CTC Alternative Strategies Ltd.
An investment management firm that significantly increased its stake in Johnson & Johnson during the third quarter of 2026.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets a broad range of pharmaceutical, medical device, and consumer health products.
The takeaway
The substantial increase in CTC Alternative Strategies' position in Johnson & Johnson suggests the firm sees strong long-term potential in the healthcare giant, despite any short-term market fluctuations. This move highlights the continued investor confidence in Johnson & Johnson's diversified business model and ability to deliver consistent returns.
